Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,051,655
+$813,664 QoQ
Shares Held
16,101
+8.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#1,449
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ranch Capital Advisors Inc. holds $19,506,059 across 8 Drug Manufacturers - General names. ABBV ranks #3 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,434 | $4,427,712 | |
| 2 | AMGN |
Amgen Inc
|
12,108 | $4,384,548 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
16,101 | $4,051,655 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
29,324 | $3,704,794 | |
| 5 | PFE |
Pfizer Inc
|
85,339 | $2,054,963 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,727 | $329,989 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,404 | $308,914 | |
| 8 | LLY |
ELI LILLY & Co
|
203 | $243,484 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,051,655 | 16,101 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,237,991 | 14,888 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,483,914 | 10,871 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,442,515 | 10,549 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,882,186 | 10,140 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,089,333 | 9,972 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,704,676 | 9,593 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,497,924 | 12,649 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,009,871 | 11,718 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,089,597 | 11,475 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,755,810 | 11,330 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $646,026 | 4,334 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $583,919 | 4,334 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $699,793 | 4,391 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $731,123 | 4,524 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $607,166 | 4,524 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $692,589 | 4,522 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $744,895 | 4,595 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $621,892 | 4,593 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $406,562 | 3,769 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $412,938 | 3,666 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $405,392 | 3,746 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $400,098 | 3,734 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $303,499 | 3,465 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $324,190 | 3,302 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $246,931 | 3,241 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||